Nanotherapeutic Technologies to Target Common Brain Cancer - AZoNano

Researchers summarized drug delivery techniques and nanotherapeutic technologies that target the glioblastoma cells that invade the brain or non-cancerous, invasion-supporting cells that reside within the GBM microenvironment.

Glioblastoma (GBM) is a malignant brain cancer in adults with a median survival period of 15 months from the point of diagnosis. Residual tumor cells that remain beyond the margins of every GBM resec… [+6515 chars]

full article...